APOA5 Antikörper (truncated)
Kurzübersicht für APOA5 Antikörper (truncated) (ABIN2464012)
Target
Alle APOA5 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- truncated
-
Immunogen
- Ni-NTA purified truncated recombinant human APOA5 expressed in E. Coli strain BL21 (DE3).
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
-
Western Blot, ELISA.
Dilution:
Western Blot:1:500 - 1,000
ELISA:Determining optimal working dilutions by titration test.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- Ascitic fluid containing 0.03 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Apoa5(bd) monoclonal antibody can be stored at -20 °C, stable for one year.
-
-
- APOA5 (Apolipoprotein A-V (APOA5))
-
Andere Bezeichnung
- Apoa5
-
Hintergrund
- Apolipoprotein A5 (ApoA5) is fast gaining attention as a key regulator of serum triglyceride concentrations. An ApoA5 mouse knock-out model produced an approximately four fold increase in serum triglyc erides, whereas a knock-in model with human ApoA5 produced 50 70 % lower concentrations of mouse serum triglycerides. In addition, peroxisome proliferator-activated receptor-_ agonists, which are used clinically to lower serum triglyceride concentrations, cause increased ApoA5 mRNA expression. Recently, it was demonstrated that ApoA5 is present in human serum detected by polyclonal antibodies against both the NH2 and COOH termini, although at much lower concentration than other apolipoproteins.
-
Gen-ID
- 116519
-
UniProt
- Q6Q788
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, Lipid Metabolism
Target
-